Evidence map›Paper›PMID 21368148›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Core promoter recognition complex changes accompany liver development.

Joseph A D'Alessio, Raymond Ng, Holger Willenbring, Robert Tjian

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Specificity Proteins (Sp) and Cancer.International journal of molecular sciences · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Mediator complex: a central integrator of transcription.Nature reviews. Molecular cell biology · 2015
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Holo-TFIID controls the magnitude of a transcription burst and fine-tuning of transcription.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Joseph A D'AlessioJanelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Raymond Ng
Holger Willenbring
Robert Tjian
University of California, San Francisco · USHoward Hughes Medical Institute · USJanelia Research Campus · US

Funding

THE SV40 TUMOR ANTIGENR37CA025417 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI TJIAN, ROBERT TSE NAN · 1987 to 2013
$6.8M
Howard Hughes Medical InstituteNCI NIH HHS R37 CA025417
6 · The paper itself

Abstract

Recent studies of several key developmental transitions have brought into question the long held view of the basal transcriptional apparatus as ubiquitous and invariant. In an effort to better understand the role of core promoter recognition and coactivator complex switching in cellular differentiation, we have examined changes in transcription factor IID (TFIID) and cofactor required for Sp1 activation/Mediator during mouse liver development. Here we show that the differentiation of fetal liver progenitors to adult hepatocytes involves a wholesale depletion of canonical cofactor required for Sp1 activation/Mediator and TFIID complexes at both the RNA and protein level, and that this alteration likely involves silencing of transcription factor promoters as well as protein degradation. It will be intriguing for future studies to determine if a novel and as yet unknown core promoter recognition complex takes the place of TFIID in adult hepatocytes and to uncover the mechanisms that down-regulate TFIID during this critical developmental transition.

Indexed as

Promoter Regions, GeneticAnimalsDown-RegulationGene SilencingHepatocytesLiverMiceReverse Transcriptase Polymerase Chain ReactionTranscription Factor TFIIDTranscription Factor TFIID

Identifiers

PMID21368148
PMCPMC3054039
OpenAlexW1988719050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.